Live Attenuated Vaccines Market Report

Global and China Live Attenuated Vaccines Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 28, 2022
  • PAGES：166
  • REPORT CODE：GMM1503128
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or "live"). Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by "killing" the virus (inactivated vaccine).

    Examples of live attenuated) vaccines include: Viral: measles vaccine, mumps vaccine, rubella vaccine and live attenuated influenza vaccine (the seasonal flu nasal spray and the 2009 H1N1 flu nasal spray), etc; Bacterial: BCG vaccine, oral typhoid vaccine and epidemic typhus vaccine.

    This report elaborates on the current development of the Live Attenuated Vaccines industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Astellas Pharma

    • GlaxoSmithKline

    • Johnson & Johnson

    • Serum Institute Of India

    • Merck

    • CSL

    • Sanofi

    • Pfizer

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Bacterial

    • Viral

    Application:

    • Hospitals

    • Clinics

    • Research Institutes

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Live Attenuated Vaccines Industry Overview

      • 1.1.1 Live Attenuated Vaccines Market Scope and Market Segments

      • 1.1.2 Live Attenuated Vaccines Industry Characteristics

      • 1.1.3 Global and China Live Attenuated Vaccines Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Live Attenuated Vaccines Production Value and Growth Rate (2017-2028)

    • 1.2 Global Live Attenuated Vaccines Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Bacterial

      • 1.2.2 Viral

    • 1.3 Global Live Attenuated Vaccines Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospitals

      • 1.3.2 Clinics

      • 1.3.3 Research Institutes

      • 1.3.4 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Live Attenuated Vaccines Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Live Attenuated Vaccines Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Live Attenuated Vaccines Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Live Attenuated Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Live Attenuated Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Live Attenuated Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Live Attenuated Vaccines Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Live Attenuated Vaccines Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Live Attenuated Vaccines Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Live Attenuated Vaccines Industry Porter's Five Forces Model Analysis

      • 2.2.3 Live Attenuated Vaccines Industry PEST Analysis

    • 2.3 Live Attenuated Vaccines Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Live Attenuated Vaccines Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Live Attenuated Vaccines Industry

    Chapter 3 Global and China Live Attenuated Vaccines Market, by Manufacturer

    • 3.1 Global and China Live Attenuated Vaccines Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Live Attenuated Vaccines Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Live Attenuated Vaccines Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Live Attenuated Vaccines Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Live Attenuated Vaccines Market Top 3 Players

    Chapter 4 Global and China Live Attenuated Vaccines Market, by Type (2017-2028)

    • 4.1 Live Attenuated Vaccines Market Trend, by Type

    • 4.2 Global Live Attenuated Vaccines Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Live Attenuated Vaccines Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Live Attenuated Vaccines Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Live Attenuated Vaccines Price Trend, by Type (2017-2028)

    • 4.3 China Live Attenuated Vaccines Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Live Attenuated Vaccines Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Live Attenuated Vaccines Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Live Attenuated Vaccines Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Live Attenuated Vaccines Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Live Attenuated Vaccines Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Live Attenuated Vaccines Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Live Attenuated Vaccines Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Live Attenuated Vaccines Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Live Attenuated Vaccines Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Live Attenuated Vaccines Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Live Attenuated Vaccines Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Live Attenuated Vaccines Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Live Attenuated Vaccines Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Live Attenuated Vaccines Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Live Attenuated Vaccines Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Live Attenuated Vaccines Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Live Attenuated Vaccines Market Analysis

    • 7.1 North America Live Attenuated Vaccines Market, by Type

    • 7.2 North America Live Attenuated Vaccines Market, by Application

    • 7.3 North America Live Attenuated Vaccines Market Analysis and Forecast, by Country

      • 7.3.1 United States Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Live Attenuated Vaccines Market Analysis

    • 8.1 Europe Live Attenuated Vaccines Market, by Type

    • 8.2 Europe Live Attenuated Vaccines Market, by Application

    • 8.3 Europe Live Attenuated Vaccines Market Analysis and Forecast, by Country

      • 8.3.1 Germany Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Live Attenuated Vaccines Market Analysis

    • 9.1 APAC Live Attenuated Vaccines Market, by Type

    • 9.2 APAC Live Attenuated Vaccines Market, by Application

    • 9.3 APAC Live Attenuated Vaccines Market Analysis and Forecast, by Country

      • 9.3.1 China Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Live Attenuated Vaccines Market Analysis

    • 10.1 Latin America, Middle East and Africa Live Attenuated Vaccines Market, by Type

    • 10.2 Latin America, Middle East and Africa Live Attenuated Vaccines Market, by Application

    • 10.3 Latin America, Middle East and Africa Live Attenuated Vaccines Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Live Attenuated Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Live Attenuated Vaccines Company Profiles

      • 11.1 Astellas Pharma

        • 11.1.1 Astellas Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Astellas Pharma Live Attenuated Vaccines Product Profiles, Application and Specification

        • 11.1.3 Astellas Pharma Live Attenuated Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 GlaxoSmithKline

        • 11.2.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 GlaxoSmithKline Live Attenuated Vaccines Product Profiles, Application and Specification

        • 11.2.3 GlaxoSmithKline Live Attenuated Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Johnson & Johnson

        • 11.3.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Johnson & Johnson Live Attenuated Vaccines Product Profiles, Application and Specification

        • 11.3.3 Johnson & Johnson Live Attenuated Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Serum Institute Of India

        • 11.4.1 Serum Institute Of India Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Serum Institute Of India Live Attenuated Vaccines Product Profiles, Application and Specification

        • 11.4.3 Serum Institute Of India Live Attenuated Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Merck

        • 11.5.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Merck Live Attenuated Vaccines Product Profiles, Application and Specification

        • 11.5.3 Merck Live Attenuated Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 CSL

        • 11.6.1 CSL Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 CSL Live Attenuated Vaccines Product Profiles, Application and Specification

        • 11.6.3 CSL Live Attenuated Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Sanofi

        • 11.7.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Sanofi Live Attenuated Vaccines Product Profiles, Application and Specification

        • 11.7.3 Sanofi Live Attenuated Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Pfizer

        • 11.8.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Pfizer Live Attenuated Vaccines Product Profiles, Application and Specification

        • 11.8.3 Pfizer Live Attenuated Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Live Attenuated Vaccines Industry Investment Prospect and Risk Assessment

    • 12.1 Live Attenuated Vaccines Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Live Attenuated Vaccines Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Live Attenuated Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure China Live Attenuated Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Global Live Attenuated Vaccines Production Value and Growth Rate (2017-2028)

    • Figure China Live Attenuated Vaccines Production Value and Growth Rate (2017-2028)

    • Figure Global Live Attenuated Vaccines Market Size and Growth Rate of Bacterial (2017-2028)

    • Figure Global Live Attenuated Vaccines Market Size and Growth Rate of Viral (2017-2028)

    • Figure Global Live Attenuated Vaccines Market Size and Growth Rate of Hospitals (2017-2028)

    • Figure Global Live Attenuated Vaccines Market Size and Growth Rate of Clinics (2017-2028)

    • Figure Global Live Attenuated Vaccines Market Size and Growth Rate of Research Institutes (2017-2028)

    • Figure Global Live Attenuated Vaccines Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Live Attenuated Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Live Attenuated Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Live Attenuated Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Live Attenuated Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Live Attenuated Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Live Attenuated Vaccines Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Live Attenuated Vaccines Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Live Attenuated Vaccines Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Live Attenuated Vaccines Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Live Attenuated Vaccines Market Share, by Manufacturer in 2021

    • Figure Global and China Live Attenuated Vaccines Market Share, by Manufacturer in 2022

    • Table Global Live Attenuated Vaccines Sales Volume, by Type (2017-2028)

    • Table Global Live Attenuated Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure Global Live Attenuated Vaccines Sales Volume Share, by Type (2017-2028)

    • Table Global Live Attenuated Vaccines Sales Value, by Type (2017-2028)

    • Table Global Live Attenuated Vaccines Sales Value Share, by Type (2017-2028)

    • Figure Global Live Attenuated Vaccines Price Trend, by Type (2017-2028)

    • Table China Live Attenuated Vaccines Sales Volume, by Type (2017-2028)

    • Table China Live Attenuated Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure China Live Attenuated Vaccines Sales Volume Share, by Type (2017-2028)

    • Table China Live Attenuated Vaccines Sales Value, by Type (2017-2028)

    • Table China Live Attenuated Vaccines Sales Value Share, by Type (2017-2028)

    • Figure China Live Attenuated Vaccines Price Trend, by Type (2017-2028)

    • Table Global Live Attenuated Vaccines Sales Volume, by Application (2017-2028)

    • Table Global Live Attenuated Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure Global Live Attenuated Vaccines Sales Volume Share, by Application (2017-2028)

    • Table Global Live Attenuated Vaccines Sales Value, by Application (2017-2028)

    • Table Global Live Attenuated Vaccines Sales Value Share, by Application (2017-2028)

    • Figure Global Live Attenuated Vaccines Sales Value Share, by Application (2017-2028)

    • Table China Live Attenuated Vaccines Sales Volume, by Application (2017-2028)

    • Table China Live Attenuated Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure China Live Attenuated Vaccines Sales Volume Share, by Application (2017-2028)

    • Table China Live Attenuated Vaccines Sales Value, by Application (2017-2028)

    • Table China Live Attenuated Vaccines Sales Value Share, by Application (2017-2028)

    • Figure China Live Attenuated Vaccines Sales Value Share, by Application (2017-2028)

    • Figure China Live Attenuated Vaccines Production, Import, Consumption and Export (2017-2022)

    • Figure North America Live Attenuated Vaccines Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Live Attenuated Vaccines Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Live Attenuated Vaccines Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Live Attenuated Vaccines Production, Import, Consumption and Export (2017-2022)

    • Table North America Live Attenuated Vaccines Sales Volume, by Type (2017-2028)

    • Table North America Live Attenuated Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure North America Live Attenuated Vaccines Sales Volume Share, by Type (2017-2028)

    • Table North America Live Attenuated Vaccines Sales Volume, by Application (2017-2028)

    • Table North America Live Attenuated Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure North America Live Attenuated Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure United States Live Attenuated Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure United States Live Attenuated Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Canada Live Attenuated Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Live Attenuated Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Live Attenuated Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Live Attenuated Vaccines Sales Value and Growth Rate (2017-2028)

    • Table Europe Live Attenuated Vaccines Sales Volume, by Type (2017-2028)

    • Table Europe Live Attenuated Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure Europe Live Attenuated Vaccines Sales Volume Share, by Type (2017-2028)

    • Table Europe Live Attenuated Vaccines Sales Volume, by Application (2017-2028)

    • Table Europe Live Attenuated Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure Europe Live Attenuated Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure Germany Live Attenuated Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Live Attenuated Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure UK Live Attenuated Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure UK Live Attenuated Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure France Live Attenuated Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure France Live Attenuated Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Italy Live Attenuated Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Live Attenuated Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Live Attenuated Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Live Attenuated Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Spain Live Attenuated Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Live Attenuated Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Live Attenuated Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Live Attenuated Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Poland Live Attenuated Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Live Attenuated Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Russia Live Attenuated Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Live Attenuated Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Live Attenuated Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Live Attenuated Vaccines Sales Value and Growth Rate (2017-2028)

    • Table APAC Live Attenuated Vaccines Sales Volume, by Type (2017-2028)

    • Table APAC Live Attenuated Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure APAC Live Attenuated Vaccines Sales Volume Share, by Type (2017-2028)

    • Table APAC Live Attenuated Vaccines Sales Volume, by Application (2017-2028)

    • Table APAC Live Attenuated Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure APAC Live Attenuated Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure China Live Attenuated Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure China Live Attenuated Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Japan Live Attenuated Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Live Attenuated Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Live Attenuated Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Live Attenuated Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure India Live Attenuated Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure India Live Attenuated Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Live Attenuated Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Live Attenuated Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Live Attenuated Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Live Attenuated Vaccines Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Live Attenuated Vaccines Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Live Attenuated Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Live Attenuated Vaccines Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Live Attenuated Vaccines Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Live Attenuated Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Live Attenuated Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Live Attenuated Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Live Attenuated Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Live Attenuated Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Live Attenuated Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Live Attenuated Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Live Attenuated Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Live Attenuated Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Live Attenuated Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Live Attenuated Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Live Attenuated Vaccines Sales Value and Growth Rate (2017-2028)

    • Table Astellas Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astellas Pharma Product Profiles, Application and Specification

    • Table Astellas Pharma Live Attenuated Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Product Profiles, Application and Specification

    • Table GlaxoSmithKline Live Attenuated Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson & Johnson Product Profiles, Application and Specification

    • Table Johnson & Johnson Live Attenuated Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Serum Institute Of India Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Serum Institute Of India Product Profiles, Application and Specification

    • Table Serum Institute Of India Live Attenuated Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck Product Profiles, Application and Specification

    • Table Merck Live Attenuated Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table CSL Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table CSL Product Profiles, Application and Specification

    • Table CSL Live Attenuated Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi Product Profiles, Application and Specification

    • Table Sanofi Live Attenuated Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Live Attenuated Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US